Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
CUIN2,
I think this news release is amazing - not simply because of what was achieved but because the company is actually communicating to us. I had to pinch myself when I saw the release LOL.
I suspect we will see a bit of rise on today for two reasons. Firstly, the private placement closed as everyone knows last Monday. Most of the financing was done by the Canadian funds (mostly hedge funds) and they have been been the sellers and simply keeping their warrants. They don't mind taking a loss because they most likely put a value on such a warrant of probably $.20 to $.40 per warrant. Much of the selling has taken place already since the deal was announced and we saw the pressure lessening today already as the the price began yo rise. This I have said in the past about how he hedge funds in Canada play. Unfortunately they have also been the funders as Titan has been unsuccessful in the US raising funds to date.
Secondly, I suspect the market will like the news. Remember, this company has kept everyone in the dark for so long - frankly causing the share price to be where it is in my opinion as well as the opinion of many others on this board. Any news of progress other than their usual stance of "we are on target" leaving us all to follow their timeline in the MD&A is great.
I truly hope that they begin putting out much more news on a regular basis. Frankly I am hoping that their next announcement which is now overdue but still expected is the news about the release of their prototype. Once that is out Titan has no more excuses about being silent in order to keep their development under wraps. They will have finally gone public with a finished product. There will be no more secrets that need to be hidden from us.
I expect them to now release news regularly on the progress of their testing etc....they have nothing hide anymore so let the news flow. At least that is what I am hoping.
Don't get me wrong, I am still pissed at management as this should have been self financed with the warrants that expire in December but the share price us now ridiculously low that it's time to be loading up.
Point
Well it looks likes the books on the Titan financing may have finally closed.
Just like last time, the hedge funds sell the stock short in order to get a free warrant (or in this case .75 of a warrant). You will start to see a recovery here.
In the interim, these guys need news. We deserve to know what is going on with the delivery of the prototype. I like many on this board were under the impression that news on this would have already been released (and strategically so before announcing the financing, but I digress). I recall that management said at the AGM that by the end of October this would have been completed (I will have to go back and watch it to re-confirm this though unless someone else remembers). Well the end of October has passed.
The prototype will make this move (in my opinion), it's just a matter of when.
Point
This is surprisingly better than I think a lot of us thought it would be - only an $0.08 discount to where it was halted.
Although they've got it and we can breathe much easier for now, this still doesn't excuse management for allowing the share price to drift down to these levels and to give shareholders the silent treatment. I understand that there's a fine line between telling the world and exposing ourselves too much, but if ever there is good information that has been released publicly, it should be press released to help the share price.
Point
Contrary, I am not bashing at all. But you don’t have to trust me.
I don’t have any issue with you being skeptical towards me. It’s all healthy discussion to understand ones position – not motive as you state.
First off, I am not bashing. I have clearly stated that Titan has the BEST technology out there from what I have been able to find. Truthfully I do learn lots from this board on the real technical stuff that I read from the people in the medical field. How on earth would I hear or learn about so much of it and so many nice specifics? I am much more a capital markets guy than a medical professional. I don’t work in an OR so in that area I obviously have a disadvantage.
That being said, I have stated that management is completely unsophisticated with capital markets and completely ignores shareholder needs. Based on that I have lightened my position.
My intention is to continue to focus on this point of management's lack of care for shareholders. Hopefully shareholders will begin to make noise, write management…….whatever works to get them out there.
Why you might ask? Because I do have shares and I do find it absolutely ridiculous that they are running out of money now and MAY have to do a financing or may have to do a JV deal that would have been less attractive to the company but due to their financial shape (in my opinion) they might be doing a lesser attractive deal or lastly they may do some type of M & A and with a share price at CAN $1.35 - where do you expect that to actually take place now. With a $1.35 share price, no one is going to do an M & A deal at $8 or $10.
I would prefer people to rise up and give management the hell they deserve.
Show me once when I have tried to negatively say that this stock deserves to under $1.00 like many of the other posts I have read on here from others. You cannot, as I have never have.
Right now the share price should be so much higher than it is so that the warrants can be exercised and Titan can self-finance. This is not the case though and we all should be upset.
Think what you want. I have no issue with it.
Just look at my points and if you agree, please reach out to management and give them your thoughts with the same energy you have been directing towards me. My partner or I have and it has been ignored.
Point
That is exactly how I feel.
Imagine what a kick in the balls it now feels like to have actually sat at the AGM and watched it live – regarding your point 4.
Point
Whoops, double posted by mistake just disregard this one
No problem.
Looking back which I subsequently did (what is that expression hindsight is 20/20) the meeting appeared to be great meeting but it really was a lot of back-patting. Other than that, nothing really came out of it. The best thing was seeing Fowler.
I expected Titan’s team to get out there and tell the story after the meeting….nothing has happened and the share price drifted.
My articles are not simply me making up information and writing them. I put a lot of time and attention into these articles and ALWAYS talk with management to confirm any facts that I might include.
The lack of the article written by me is due to the lack management getting back to me or my friend/partner. I need more than Steve Randall returning my calls to confirm facts that he cannot actually confirm. Both Rayman and Hargrove were reached out to with no response – hence no article.
Do what you want and believe what you want. Whenever I said I would follow up with something, I did, whenever I said I would publish something I also did (with the exception of my last article). This was based on the management team being cooperative and confirming and sharing information.
Neither Bertner nor management will return calls so I am SOL. Bertner considers herself “institutional IR”. Wow - $20k per month and lots of institutions – NOT.
Nothing would make me happier than a shareholder friendly management team with a share price increasing.
Point
Guys, I'm sorry about the other post. It was done in poor taste as I 100% should not have mentioned another company on this board. I apologize and it won't happen again. That said, I still stand by my feelings 100% on how management neglects shareholders.
Point
Not an issue.
I was not pumping by any stretch any other stocks. In fact I clearly stated most could not even buy as they were not US listed.
Regarding my points about management, I am spot on. This company needs a capital markets savvy CEO who is also investor friendly. No news or presentations to shareholders or buyers. Of course presenting at healthcare conferences like this past weekend is one thing (again mostly business related only) but that is not like doing the tour of duty and presenting the company to investors.
I still have significant position and have no regrets about lightening up at all. I am not a perfect investor either as I have been in since pre-public and probably could have done other investors but I am a long term investor and do not trade. Selling some of my position after 6-7 years is long term.
I will re-establish my position at some point and I don't mind paying higher prices either.
Right now I just don't see it. Company needs money in the near future and it makes me nervous on how they will get it.
I see three options: 1) Will they go to market? 2) Will they announce a JV? or 3) Will they announce an M & A deal?
The only thing that helps us shareholders is a JV deal (hopefully). If they go to market, it will more than likely be at a discount to current share price. If they announce some type of M & A, then how much of a premium will it be at? Let's say a double - no, let's say a triple but no more than that. Look at industry averages - they don't pay on average 3-4 times premium. If we use 3 times though that only gets us to around CAN $4.00. Not so good considering what they have - but today that is realistic.
This is managements fault and I am not changing my stance.
Is the product good? No, it's great. Do they have all the surrounding patents? Yes. Is there tremendous value? Yes.
We should not be in the position we are in.
A shareholder friendly management would have this price higher, at least close to or around the last financing price. If that were the case then warrant money would be coming in. No warrant money is coming in. The financials show that. No changes on warrants. See for yourself - I looked.
Whose fault is that? Management. Period and end of story.
Based on that I took some money off the table. As stated earlier, these guys went public in June 2008. That's over 7 years ago. I have been in this longer than you. I have also been purchasing all the way up as well including in every single financing. Now I start to see even my original 5 year warrants look like they will fall off the table.
Once I know their financing strategy going forward as I stated earlier in my post, I might buy back what I sold. But only when I know what is going on.
I am not a doctor or one of the healthcare professionals on this board but I have been in the past extremely active here. I was as bullish on Titan as anyone here knows. I gave as much as I could on this board relating to the capital markets when everyone else was freaking out on the financings.....
I pulled back after I realized management is focussed only on what they want to do. They are a public company and take money from investors. They have to report back to investors and do things to also support their share price. Period. They not only have to run a company but they have an obligation to also run the capital markets dude if their business. They have not done a poor job, they have done a zero job. Their excuse is that they have someone doing that. How is that working out? Does she take your calls? No. She is institutional IR only. Well what use us that when most of your float is owned by retail in both the US and Canada.
I stand firm on this. Been around longer than many of you in this (just lightened up as I fully disclosed) and frustrated by management.
I recall someone over the weekend saying we should stand up and yell "we are not going to take it any more". Been doing that for a long time and where is that getting me/us? Nowhere!!! The only place I see is back to another financing.
I cannot wait to see what is coming - though I hope a JV.
Point
While I love the product, management continues to blow a good thing.
I still continue to own a healthy position however unloaded about half or a little more than half my position.
I would enter but only after I see what their financing plans are.
If they have to go to market they will need to do something at a discount to the current share price, I may as well wait.
Right now I have significant gains on some investments that if they peak out I would look at coming back to replace my original position. The other investment I am down on but will hold, I think their is a triple coming this next year and I will lighten up a little later on and then would re-establish my position.
See my earlier post.
Point
You sir are 100% correct in both your points 1 and 2.
Both myself and my friend have been in Titan since day 1 - in fact sort of before day 1 as we participated in the PP before it went public. So that being said it went public in June of 2008 and we both lightened up our positions in March / April /May. We really turned on harder selling around April/May and were probably even a little responsible for driving the price down through the $1.50 range (I am talking CAN - it's now about $1.35 now).
Management could potentially be the worst management team for a public market company I have ever seen. They care ZERO about shareholders in my opinion (and by my opinion I mean both mine and my friends - who even after selling a substantial position probably still might be one of the largest retail shareholders of Titan) and don't deserve our money.
Hargrove only cares about the project and has no idea how to run a public company with shareholders. He should be president only and they should hire a proper CEO who knows both capital markets and public markets. Rayman should be COO. Nice guy but cannot make a decision. Talk to him and it's always "yes" to everything. Give him ideas or constructive criticism and you get agreement and then no follow up.
As shareholders they have F_ _KED us.
Positives are that they have an amazing product. More negatives are they screwed the shareholders in that if they were to have a product today the most on average a company would pay for this company would be a double. Let's be real positive and say a triple. Wow, after all the money these guys have raised $4.00?????
They have killed this. Just because you get the FDA does not mean your market cap jumps to $2 or $3 billion over night.
Anyway, they are doing a great job on the product but you will never get what we really should be getting if they focussed on treating shareholders properly.
I hope they have a real plan for funding as they are out of money by my calculations by December. This was based on how much cash they had in the bank when we were at the AGM and what their burn is.
I have no idea what is in store for us shareholders but they will need money.
If management had spent time talking to shareholders sad promoting the Titan story their share price would be higher. They did none of that - at least in Canada. Why do I mention Canada? Because that's where all their financing were done. No real significant US institutions stepped in so you need to keep your shareholders happy - which they have not done as reflected by the price.
So all that being said Titan management had the bull by the horns and blew it. If they had treated shareholders with respect and promoted even a little bit they might have a higher share price and the warrants would be exercised. Where are we now? First set soon to expire worthless. All managements fault. They should resign with their heads hung in shame. Note: Fowler is not included in this mess. He has nothing to do with it.
FYI, Randall is amazing. He gets it but his hands are tied. They also need to get rid of dead wood directors too. All just my opinion.
To answer the second part of your question, yes I / we took lots if money and invested it into some other deals. I will discuss a couple very briefly.
One deal will be listed in the next 30-45 days or on the US market - the QX like Titan is currently. It's called Golden Leaf Holdings and the symbol in Canada is GLH. It's by far the best marijuana play on both sides of the border (Cabada and US).
The company is operating in Oregon and is the largest producer of oils and edibles. Correctly they have revenue in the range of $1.2 million per month and they are capacity constrained - until now. Last month they had 2 new machines come on stream, this month another 2 and next month another 2. This will more than double their revenues to over US $25 million per year. They are actually shooting for $60 million.
Margins with purchasing their trim are 40% however they have their own facility coming on stream where they expect to be able to grow enough trim (not including the flower) to satisfy almost whatever their machines can produce drive the margins to 80% or higher.
The company is run by one of the best CEO's I have met so far - formerly CEO of Mars Canada (Mars as in Mars Bar) as well as Cara Foods which just has a very successful IPO and Don Robinson retired from Cara in December 2013 before becoming bored again.
If you compare GLH to the current market leader in Canada Canopy Growth Corporation - CGC who has a market cap around $200 million, losses money each quarter and has revenue in the $600,000 range for the quarter, Golden Leaf Holding becomes a no brainer. It's got 62 million shares outstanding and closed at CAN $1.34 on Friday. This should have at least the same market cap as CGC. Lastly, they have shareholder friendly management unlike TMD. Both my friend and I got in the pre-public round last August when it had almost no revenue and we have been on the open market at these levels. Last purchase was as high as $1.25 for full disclosure.
I will be publishing a lot on this company and if anyone wants some info please feel free to inbox me direct.
The other company we invested in heavily and are down on it but not even concerned a bit is a company Distinct Infrastructure Group. This will do exceptionally well given the Liberal Government has just gotten into power in Canada and will be spending billions on infrastructure.
They have about $33 million in revenue and I expect to see closer to $100 million in the next 12 months or less through organic growth and acquisitions.
This might be less attractive to the US investors on this board as they will not be getting a US listing. They trade under the symbol DUG.
There are a few more investments that have worked out better than holding Titan so I have no regrets. FYI I /we still hold a substantial position and are trying to decide on what to do.
If they do a financing which they will need sooner than later it will most certainly have some type of a discount to the market - probably 10% to 25% on the high side. This will drive the price down again.
Anyway, sorry for being long winded but I say it as it is.
Still a little long but NOT as strong
Point
Hi everyone,
Just checking in to see how everyone is doing these days.
What a crazy time it has been in the markets. The volatility caused by China slowdown fears and now all the healthcare stocks being hammered due to Hilary's comments. Some of these stocks are down 60% to 70%. Crazy times.
I trust most are in good spirits though.
Just browsed the board and saw many familiar names including longtermjems hahaha. Anyway, ignore him. Not really sure why he comes to the board at all.
Just though I would check in - lightened up on my position as did my friend but still own TMD.
I will probably spend a little more time reviewing the board to keep an eye on things a little more closely. Have been in this since the day it went public so by lightening up it was not the end if the world.
This is still the most enlightening and professional board out there. I should have kept more on top of things but simply got busy.
Looking forward to reading your posts.
Point.
*UPDATES FROM THE AGM*
Hi All,
I know I haven’t been on here in awhile, but I definitely didn’t forget about you guys – I’m just working on a lot of projects that have been taking place simultaneously and I simply haven’t had the time to get on here consistently over the past ~6 months. That said, I figured that you’d all appreciate an update on the AGM. To add further to what JUrology contributed, here are some of my notes:
In short, I was blown away by the new images and videos that were shown during the presentation (one-off and totally different than anything we’ve ever seen before). Everything looks incredible. Despite the setbacks that the company has had, it seems that things are progressing very well on the research and development side of things. The sales strategy and planning has also begun. I’m still extremely disappointed by management and their lack of commitment to shareholders to press release information that is in the public realm and support the share price - especially because they will be out of money by year end. My friend voiced this opinion quite clearly, asking a long question surrounding management’s compensation plan and voting against it as well. As an investor, you have to decide whether or not you want to hold until we have some actual catalysts on the horizon. Time-money value is a tricky thing. That said, I really think that this is going to be a home-run as long as you’re patient. Long and strong.
Hopefully you’ll find some good information below:
Financial Snapshot:
As at March 31, 2015 – Share Price $1.43; $27.4M cash and cash equivalents; Shares Outstanding increased to 102.6 million or 105.2 million fully diluted; MC $146.7M or $150.5M; Management owns ~6.2%; Warrants about 39M out, and about $80M to potentially come in
Discussion around the clinical, financial and operational challenges faced by customers including: Capital equipment downtime/utilization; Surgical scheduling and procedural planning; staff morals; increased patient wait time; patient satisfaction stories; staff retention and operation; workflow; capacity; and revenues
Discussion on the importance of value-based account management deliverables. This was a recurring phrase throughout the presentation.
Discussion on voice of customer feedback from industry sources including: 1. GPOs; 2. IDNs; 3. Acute care hospitals; 4. Health systems; 5. Academic medical centers; 6. Ambulatory care centers; 7. DOD/VA hospitals; 8. Professional healthcare organizations; 9. Large healthcare insurers; 10. Center of Medical Services (CMS); 11. American Hospital Association; and 12. Surgeons in North America, Europe and rest of world
Discussion of SPORT based on a “Scouting Report”. Talked about surgeon experience statistics on low-volume surgeons and the tiered procedural approach being used by hospital administration.
Discussion on SPORT features including: Teleoperation; 3-D stereoscopic imaging; restores intuitive control; enhanced or new functionality; and enhanced ergonomics (much more comfortable workstation); design is pretty much finalized.
Discussion on enhanced functionality including: Enhanced 32” HD 3-D display from Sony; Improved dexterity; Outstanding controllability; Information delivery with a 2nd display; Automated functionality; and data collection and analytics for the surgeon and/or OR team (time, instruments used, for how long, etc.).
Discussion on Works-Like Workstation. Wanted to show more photos, except patent counsel advised against it; patents forthcoming maybe in days
Discussion on Looks-Like Workstation. Built using CAD of final design of workstation; a few photos shown over the next few slides; You need to wear glasses for the 3-D effect.
Discussions on Patient Cart, Works-Like Patient Cart, Close-ups of Central Unit, Insertion Tube, Camera Module and Robotic Arms, and Tools.
Video of Dr. Valvo performing surgery with the SPORT.
Discussion on training including curriculum, creating learning experiences, performance assessment, and training partners.
Regulatory update on FDA and CE Mark.
Q&A Highlights (paraphrased):
Question 2.
Q: Question of cash burn
A: [Randall] Current burn rate is about $3.3 million/month
Question 5.
Q: There’s a consensus out there that Titan is under a big “cloak of secrecy” in regards to protecting our assets. I was wondering if there’s a marketing plan in place with a road map to inform investors?
A: [John] Per the Sony contract, that is why they have not announced right now. We will be seeing more press, the company has a game plan in place that starts with the hospital and the customer.
Question 7.
Q: There has been no mention of shareholders since the formal part of the meeting. I voted against the option plan. I would like to understand the compensation plan and who is responsible for it. I’d like to understand about the option plan. Please elaborate on that because the company will be out of money sooner than later. Concerned about shareholder value.
A: [John] As far as employees and management are concerned, they believe they bring quite a value and everything is justified.
[Randall] We are paid reasonable, below-market salaries. The real end game is becoming commercial, hence the incentivized option plan. That’s where the “real” money is for management and shareholders. We are extremely well aware of the status of the warrants.
Question 9.
Q: How many acutal prototype machines have been built today?
A: 2 machines will be built by October and 7 by the end of the year. 7 in total.
*HOPEFULLY* a video of the AGM will be put up in the coming days as Titan had a videographer filming the event.
I am working on a Seeking Alpha article right now which will include a lot more detail than these rough notes. It will hopefully be out in the next 24-48 hours.
If you have any more specific question I’ll try to answer them as best as I can. Either post on the board or private message me.
Long and strong.
Great news. The market should respond accordingly.
Management still isn't issuing news like we'd all like to see, however at least they're concentrating on the task at hand and meeting the milestones that they've laid out. Things should hopefully start to get more and more exciting here once again as manufacturing of the clinical prototypes ramps-up heading into the design freeze and then first in-human studies.
Long and strong.
Here are some links to bio pages for Dr. Mohammed:
http://linkd.in/1F93ZgI
http://bit.ly/1F93ZgM
The fact that an ex-GW exec. has now joined the team at InMed is a huge testament to the validity of the technology and what the company is working towards.
What a busy week so far!
Thanks for the kind words, much appreciated. The board here seems like a great to find and discuss info. about the company, I'm now glad to be apart of it.
This should be a GREAT presentation and Q&A session! Should be quite informative for investors to hear directly from the mouths of the senior management team about what they've been working on and how they plan on growing the business.
DATE: Thursday, March 5, 2014
TIME: 1:15pm ET
LINK: http://bit.ly/1BCPWRx > click the red "register/ watch event now" button
This will be a live, interactive online event where investors are invited to ask the company questions in real-time - both in the presentation hall as well as InMed's "virtual trade booth." If attendees are not able to join the event live on the day of the conference, an on-demand archive will be available for 90 days.
I completely agree PharmaGreen, and even at that, it's mainly people out of Western Canada that have been buying. The Toronto/Montreal markets haven't even got started yet. As the company starts rolling out steady now (now possible since they're all cashed up), the U.S. crowd will start to grow as the story develops. Tiberend apparently did a good job in SF, and is now lining up other events.
Numerous people were apart of the deal, you can review the Form 9 filed with the CNSE here:
http://www.thecse.ca/cmsAssets/docs/Filings/2015/2015_02_26_15_13_49_IN_Form_9_-_Notice_of_Proposed_Issuance_of_Listed_Sec.pdf
I took a piece of it, and know a number of others who did as well. All very strategic, long-term individuals.
I'm the author of that article and if anyone has any questions, feel free to ask me anything.
No IITF, no one has asked myself or friends to borrow any shares.
Good find, these guys are notorious for their short calls... however they have no idea what is going on.
They are just looking at the recent quick rise in the share price and calling for a pullback (based largely on technicals). They don't realize that the stock has already overreacted and had a large pullback a few months back due to the time line increase, and that news is due out shortly.
The article is crap and they have probably not spoken to the company or done any material due diligence.
This is still a good accumulation area in my opinion (obviously a couple weeks ago would have been better, but nonetheless).
Long and strong.
Pretty good article on the company by Moriarty - thanks for posting!
Scout DS® is cleared for sale as a screen for pre-diabetes and type 2 diabetes in Canada, Mexico, has been CE-Marked for the EU, with pre-submission documentation for a de novo classification in process with the FDA (1Q2015).
Miraculins holds a strong patent portfolio with multiple patents issued in the U.S., multiple pending patent applications, and patents issued/pending in Europe, Canada, India, Japan, China and Korea.
The company has proprietary encrypted algorithms and instrument standardization methods and materials.
In addition, there has been about $40-$50 million invested in the researching and developing the technology.
Compared to traditional screening methods the process of testing through traditional screening methods can be very difficult and often quite cumbersome for the person involved to the point where the tests become ineffective because people haven't followed proper procedure. Many of these tests require 8-12 hours of fasting, not to mention all alternatives to the Scout DS® are invasive (a big turn-off for those put off by needles and even less reason to be tested in the first place). Since 1 out of 4 of those with Type-2 diabetes are unaware they even have the illness, and 9 out of 10 are unaware they have pre-diabetes, therein lies the very compelling opportunity to encourage people to get tested regularly.
A Few Facts on Diabetes
Diabetes is a silent killer. It is a global pandemic and becoming a major economic problem for our society. Its impact is significant and is only getting worse each day:
•There are 387 million people with Type-2 Diabetes in the world
•World diabetes cases are expected to jump 55 percent by 2035
•Diabetes is the fastest growing disease in history, consuming a disproportionate share of healthcare budgets (over $245 billion is spent annually in the U.S., and over $612 billion is spent worldwide)
•Complications are costly and debilitating. They include: blindness, kidney disease, cardiovascular disease, nerve damage, erectile dysfunction, amputation, and death - every 7 seconds 1 person dies from diabetes)
•Loss of productivity adds significantly to the societal costs of diabetes
•Early detection by screening is key. Multiple studies have shown that with early detection and intervention, the majority of diabetes cases can be prevented
•Interventions are available, scalable, and provide enormous cost-savings
•According to United Healthcare, there is an Incremental cost of $37,000 per patient, per year resulting from the progression from pre-diabetes to diabetes
•Public health organizations, payors, and governments are launching initiatives to combat the issue
Introduction to Miraculins
Winnipeg-based Miraculins (OTC:MCUIF) (or TSX-V: MOM) is a medical device company focused on developing non-invasive diagnostic tests and risk assessment technologies that address unmet clinical needs. The company's two primary medtech programs are in the early commercialization phase in the areas of diabetes and cardiovascular disease.
The diabetes program is focused on the Scout DS® non-invasive diabetes screening test, the first non-invasive diabetes screening system designed to provide an accurate, reliable, and convenient method for diabetes screening based on related biomarkers present in the skin. The technology has previous commercial sales outside of the U.S., and Miraculins is working to continue to build momentum in the marketplace.
Miraculins cardiovascular disease program is focused on the PreVu® Non-Invasive Skin Cholesterol Point-of-Care ("POC") Test, a non-invasive tool to assist with the risk assessment of coronary artery disease ("CAD").
The introduction of new medical device technology into the marketplace is a complex and multi-faceted process that often involves long buying cycles and requires multiple pilot testing programs. These pilot programs, which allow for market feedback to be secured under controlled distribution scenarios, provide important information ahead of future commercial launches. Different market segments require different strategies and different levels of investment to successfully penetrate. This is largely where the company is at now - figuring out a marketing strategy. The technology has been developed and built, now the company needs to focus on sales and distribution in international markets, particularly Europe, Canada and Mexico, while working towards achieving FDA clearance in the U.S., and CFDA approval in China.
The was a stunningly spectacular loss by the Seahawks. Why they didn't live and die by Marshawn Lynch, I'll never know. Crazy passing pass!
It's okay though, new Champs, new Titan! Let's see that positive momo continue next week. Like Adrock said, Beast Mode for Titan will have to do!!
Long and strong.
It's nice to see Titan behaving the way it should be.
There was really not a major reason for the share price to have dropped the way it did after that change in timeline. Frankly it was an over-reaction and went down too far.
The reality is that as everyone knows, Titan increased the number of potential surgeries/procedures it can do now (hence the increased timeline) so it has actually created substantiality for itself.
I've been adding shares lately, and my friend who is a significant shareholder has also started to buy again (including today) now that the momentum has turned again.
As usual, I will keep you posted as I hear anything.
Long and strong.
Great to see at least someone is still paying attention to this board! It seems like it had quite the following. I just posted a fairly thorough Instablog on Seeking Alpha. and as soon as I am approved to become moderator for this board, will update the sticky section at the top with it.
Here is a link if you're curious in the meantime:
http://seekingalpha.com/instablog/27523743-point-of-return/3686746-legal-drug-war-how-vancpharma-is-taking-advantage-of-the-patent-cliff-in-canada
Compelling opportunity to invest right now given:
(1) the recent pullback in share price;
(2) the significance of forthcoming news releases to act as catalysts to unlock shareholder value;
(3) management’s achievements to date and their track record to deliver results;
(4) market opportunity (>$1 billion on current portfolio) and attractive valuations of sector peers;
and (5) lack of competition in the Western Canadian generics market and the opportunity to generate imminent revenue.
Simple business model - Vanc sources drugs that have already obtained FDA equivalent approvals through affiliated companies in China and India, in exchange for manufacturing rights when the drugs are approved by Health Canada.
This has been quarterbacked by CEO Arun Nayyar, who has an extensive track record in the generics industry, having held executive positions with pharma companies in Latin America, Asia, and Canada and has played an instrumental role opening up new markets abroad
When compared to some of the other generics companies, Vancpharma looks very undervalued based solely off of its standing drug portfolio, not to mention its ability to scale quickly.
The two best comparables that come to my mind are: Paladin Labs and BioSyent.
Vanc Pharmaceuticals is nothing like the company it used to be.
Since the new management team stepped in, Vanc has completed revamped its business model and is now focusing on providing Canadian healthcare professionals and consumers with high-quality, affordable generics and over-the-counter ("OTC") healthcare products.
It's okay CUIN, you've been in Titan since the get go. It's understandable to get frustrated and beat down along the way. Like I said before, I respectfully understand the decision - sometimes you just need to move on from an investment.
I'm glad that you've done well on Theralase! They have some great tech., Roger is a stand-up guy and very on point with capital markets. I still hold a small, core position.
I met with the CEO of another medical device company this week, and I am going to write an article on it. It's called Miraculins Inc. (MOM in Canada, and MCUIF in the U.S.). Interestingly, the same HNW investor who turned me onto Theralase is heavily invested in Miraculins as well (he organized the meeting this week with Chris, and also provided my introduction to Roger).
Titan is under capitalized to get to market with SPORT, but a lot can and will happen between now and then. I'm in the camp that the PPS will be supported by management and Sherry Bertner. Not only through keeping the market more informed and her institutional contacts, but also by Titan forming strategic partnerships with others in the industry for development.
I actually think the next grow catalyst will be when the design freeze occurs ("Design and test of feasibility prototype complete" Q1 2015). The freeze signifies when detailed design phase has been completed and at which point the final version of the technical drawings are signed off and released to production.
So, when the design is frozen the product can be manufactured - there will be no more changes to the design of the machine at that point (unless it's changes like safety issues or problem corrections). Further cost reductions that are discovered will have to be implemented in the next product generation.
I think that the significance of that shouldn't be understated, and the market will react if/when they accomplish this milestone on time.
You commented on how management can be trusted, and I can't argue with that, when twice now they've changed course - you'll have to make a judgement call on that. Our friend CUIN is not happy and has mentioned that next time there is share appreciation he's going to look for an exit. It's unfortunate, however he is not alone in feeling this way, all longs must to some degree, and I respectfully understand their decisions.
However, when the design is frozen the next stages are all in Ximedica and Dr. Fowler's hands, and I believe that they are both extremely capable.
The next milestone will be engineering completion Q4 2015, and Titan can start showcasing its machines in participant hospitals for clinical trials. Word will spread quickly if it's the machine that we all believe it will be, so I think that a lot will happen before human clinical trials. Yes, money is an issue, but there will be opportunities to support PPS and get the warrants exercised if management stays the course here and meets milestones on time or early.
My call HC, they wanted it out ASAP. It took a while to finish the article. After the first interview with JH and RR (Nov. 17), I had to wait and co-ordinate the second with Fowler (Nov. 26), then I was away on three business trips (two to Vancouver, and one to Ottawa), and before I knew it, it was the holidays. I figured that I had time to finish and publish the article then, but thought that the market reaction would be poor given that most people were away, so I decided on the New Year. The New Year came, I submitted the article to SA, the editors required a couple of turnarounds from me in order to get published, and it ended up coming out this week. As a member of the community here, while I appreciate all the thanks, I genuinely feel bad that I didn't publish sooner because I know how eager all of you were to hear the details, so for that, apologizes.
I lol'd at "DUCKS for BUCKS", too bad, get 'em next time!
Where are you visiting when you're coming up here? I'm based out of Toronto, but regularly travel to Vancouver, and less frequently, Ottawa and Montreal. If you're ever around and our schedules align we should have a drink. Weather permitting, definitely a round! I've actually golfed here in the Greater Toronto Area in January, and three years ago was playing 4-5 rounds a week in shorts in March. It's been a mild winter here, so maybe that will continue into Spring.
I agree, words only mean so much. To hear peoples' tone and inflection while conversing makes a big difference in driving the point home. I'm hoping that next time I interview Titan management, it will be a video interview that I can post online (at the least, some audio that I can turn into a podcast and transcribe the text). To highlight just one example, I could tell that John sounded much, much more committed to keeping shareholders informed going forward. This has been a big point of contention between him and I before, and I could tell just by hearing his voice that he was now at least in agreement and recognizes its important. Retailers hold the majority of this company and need to be kept informed in order to support the PPS. There's still the matter of protecting the IP, but at least he's going to put his best foot forward to keep us all as up to date as possible.
I don't work in the medical community, but I always appreciate the insight that you and everyone else on here that is brings to the discussion. It seems like the med device world is quite small, by that I mean people know people and words travels quickly, and I too think that when the prototypes get out into the market, word will travel very quickly and people will realize what Titan has going on. Like jetuomi mentioned, when Titan transitions from a development stage company, into a clinical stage company, that usually follows by a bump in the PPS. I believe wholeheartedly that the medical community will get behind this. And when I hear all of the great feedback on SPORT from the much more knowledgeable people on this board than myself, it further reassures.
My friend running a book holding millions of warrants is not concerned about them at this point in time. He probably is the largest retail broker in Titan, and also holds a significant personal position. Going back to the tone and inflection of voice, he was as cool as a cucumber when I discussed this with him just a couple of days ago.
Long and Strong.
Thanks scalpel. I just contribute what I can, I'm glad that you enjoyed the article. It's the people here day in, and day out, reporting back from conferences, digging up new patents, and gems of information from scouring the internet and social media who really make this board what it is though.
Not to mention, I really only began writing on SA after originally being encouraged by people on this very board - so thank you.
Sometimes we can all get a bit discouraged, and when people are down and not hearing anything from the company for a while, well, wandering minds drift. Sometimes things get heated in here. But ultimately, most of us have the same objective in mind and just want what's best for the company.
Let's keep up the great discussion! Almost @ 20,000 posts for the TITXF board.
That's good DD jetuomi. I concur with your implications as well.